Doreen McBride, PhD

Head, HTA Health Economics Strategy and Research

PhD, Medical Sciences
Humboldt and Free Universities of Berlin

University of Leicester, UK

BS, Healthcare Administration
College of Mount St. Joseph, Cincinnati, OH, US

Doreen McBride, PhD, is Head, HTA Health Economics Strategy and Research at RTI-HS. Dr. McBride has more than 30 years of experience in health care administration and research. She has a proven track record in the successful design, implementation, and leadership of large-scale multinational health economic and epidemiological studies throughout Europe and the US, and leads integrated teams for health technology assessment submissions. She has provided successful leadership and oversight of research in a number of therapeutic areas, including cardiology, dermatology, diabetes, nephrology, oncology, allergy, and rheumatic diseases. She also has conducted patient studies in the assessment of treatment preference, patient satisfaction, treatment and economic burden, health-related quality of life, and productivity.

Dr. McBride is an active member of the International Society for Pharmacoeconomics and Outcomes Research, Health Technology Assessment international, and the German Society for Health Economics. She has published in peer-reviewed journals and has presented her research at numerous international symposia. She also serves as a peer reviewer for Value in Health, the American Journal of Geriatric Pharmacotherapy, and the Journal of Thrombosis and Thrombolysis.